Equatorial Guinea has confirmed its first outbreak of Marburg virus, related to Ebola, with a fatality rate of up to 88%. Health officials worldwide are urgently testing whether experimental vaccines can protect against the deadly illness. The World Health Organization has convened an urgent meeting to discuss the feasibility of testing Marburg vaccines in Equatorial Guinea. But control measures such as quarantine could end the outbreak before a single vaccine dose can be administered. Only the Sabin and Janssen vaccines have been tested in humans, and availability ranges from a few hundred to a few thousand doses.
Related Posts
Nanoplastics Influence Alpha-Synuclein: Insights into Parkinson’s Disease
A study led by Duke University reveals a correlation between nanoplastics, derived from polystyrene, and alterations in brain proteins linked to Parkinson’s disease. The research, conducted in solutions, cultured cells, and genetically modified mice, indicates an abnormal accumulation of alpha-synuclein proteins in the presence of nanoplastics. Notably, strong chemical bonds form between polystyrene nanoparticles and […]
The Red List of Dipterocarpaceae
The Red List of Dipterocarpaceae refers to an assessment that categorizes species within the Dipterocarpaceae family based on their risk of extinction. The Red List is a conservation tool managed by the International Union for Conservation of Nature (IUCN) and is widely recognized as one of the most comprehensive resources for assessing the conservation status […]
Probiotics vs Paraprobiotics
Probiotics: Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. These are typically found in fermented foods like yogurt, kefir, sauerkraut, and kimchi. Probiotics contain beneficial bacteria strains such as Lactobacillus and Bifidobacterium. Paraprobiotics: Paraprobiotics, on the other hand, are non-viable microbial cells or cell fractions of […]